Evidence map›Paper›PMID 42403856›Full record

ArticleCureus2026

Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Eosinophilic Granulomatosis With Polyangiitis Presenting With Refractory Asthma, Mononeuritis Multiplex, and Cutaneous Vasculitis: A Case Report.

Khaled M Malkawi, James Beynon, Hitasha Rupani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khaled M MalkawiNIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, GBR.
James BeynonRheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, GBR.
Hitasha RupaniRespiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis characterised by asthma, eosinophilia, and eosinophil-rich tissue inflammation. Early diagnosis is often difficult because initial features may resemble uncontrolled asthma or other eosinophilic lung diseases. We report a 66-year-old man with adult-onset asthma who presented with four months of progressive dyspnoea, constitutional symptoms, peripheral neuropathy, and cutaneous vasculitis. Investigations showed marked eosinophilia (19.1 × 10⁹/L), raised inflammatory markers, elevated creatine kinase and lactate dehydrogenase, and markedly elevated IgG4. Cross-sectional imaging showed calcified mediastinal and hilar lymph nodes without pulmonary infiltrates. Extensive infectious and haematological investigations were unrevealing. Anti-myeloperoxidase antibodies were positive, and skin biopsy confirmed small-vessel vasculitis with eosinophilic infiltration. A diagnosis of ANCA-positive EGPA was made. The patient was treated with high-dose corticosteroids, but symptom recurrence during steroid taper prompted escalation to intravenous cyclophosphamide for organ-threatening neurological involvement. This case highlights the importance of considering EGPA in patients with refractory asthma, eosinophilia, and systemic features even in the absence of pulmonary infiltrates. Early recognition and multidisciplinary management are essential to reduce irreversible organ damage.

Indexed as

adult-onset asthmaanca associated vasculitisatypical egpaeosinophiliaeosinophilic granulomatosis with polyangiitismononeuritis multiplex

Identifiers

PMID42403856
PMCPMC13332705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.